Loading stock data…
Teladoc Health, Inc. (TDOC)
$6.26-0.02 (-0.32%)
Market ClosedLast close Sep 8
Teladoc Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Teladoc Health, Inc. in the Healthcare sector is trading at $6.26 with a market capitalization of $1.2B. Wall Street consensus targets $7.67 (18 analysts), implying a +22.5% move over the next 12 months. The stock is currently 37% below its 52-week high of $9.89, remaining 6.3% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +22.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $606.93M↓ | $613.85M↓ | $642.27M↑ | $626.44M↓ | $631.90M |
| Gross Profit | $416.09M | $416.32M↓ | $445.22M↑ | $439.26M↓ | $441.36M |
| Operating Income | -$34.50M↑ | -$48.73M↓ | -$26.97M↑ | -$35.46M↑ | -$46.03M |
| Net Income | -$38.91M↑ | -$63.84M↓ | -$25.14M↑ | -$49.51M↓ | -$32.66M |
Peer Comparison
JNJUNHPFE
Fundamentals
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical se...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.24B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.13
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-13.54%
Volume
Today's trading volume
3.76M
Recent News
2 Beaten-Down Stocks to Avoid Right Now
Don't catch a falling knife.
Here's Why Teladoc's Integrated Care Business Deserves More Attention
TDOC's Integrated Care is driving profitability as chronic care gains traction, potentially making it the company's key earnings driver.
Here's Why Investors Should Stay Neutral on TDOC Stock for Now
Teladoc Health's growth is supported by chronic care, international expansion and Teladoc One, but BetterHelp weakness and losses temper the outlook.
3 Reasons to Sell TDOC and 1 Stock to Buy Instead
Over the past six months, Teladoc has been a great trade, beating the S&P 500 by 11.4%. Its stock price has climbed to $6.36, representing a healthy 23.2% increase. This run-up might have investors contemplating their next move.
Teladoc (TDOC) Down 3.3% Since Last Earnings Report: Can It Rebound?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.